Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Bio-Technology General (NasdaqNM:BTGC)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials
Location
70 Wood Avenue South
Iselin, NJ 08830
Phone: (732) 632-8800
Fax: (732) 632-8844
Email: information@btgc.com
Employees (last reported count): 325
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 600 SmallCap
Ownership
·Insider and 5%+ Owners: 8%
·Over the last 6 months:
 · 9 insider sells; 65.0K shares
  (1.4% of insider shares)
·Institutional: 52% (57% of float)
(198 institutions)
·Net Inst. Buying: 13.3M shares (+30.56%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Bio-Technology General Corp. is engaged in the research, development, manufacture and marketing of biopharmaceutical products. The Company has developed a portfolio of therapeutic products, including eight products that have received regulatory approval for sale, of which seven are currently being marketed. Additionally, the Company has four products in registration or clinical trials and several products in pre-clinical development.
More from Market Guide: Expanded Business Description

Financial Summary
BTGC is engaged in the research, development, manufacture and marketing of biopharmaceutical products through a combination of R&D, acquisition, collaboration and licensing agreement. For the six months ended 6/30/01, revenues rose 49% to $61.9 million. Net loss before accounting change totaled $29.1 million, vs. an income of $6.7 million. Results reflect increased sales of Oxandrin, offset by a $45.6 million charge for the write-off of purchased technologies.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Sim Fass, Ph.D., 59
Chairman, CEO, Treasurer
$555K--  
John Bond
Sr. VP-Fin.
--  --  
Robert Shaw, 47
Sr. VP, Gen. Counsel, Sec.
296K$60K
Norman Barton, M.D., Ph.D., 53
CMO and Sr. VP
292K720K
Dov Kanner, Ph.D., 47
Sr. VP; Gen. Mang., BTG-Israel
320K--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:BTGCAs of 31-Aug-2001
Price and Volume
52-Week Low
on 16-Apr-2001
$3.64 
Recent Price$9.50 
52-Week High
on 1-Sep-2000
$14.063
Beta1.71 
Daily Volume (3-month avg)417.5K
Daily Volume (10-day avg)201.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-30.9%
52-Week Change
relative to S&P500
-7.3%
Share-Related Items
Market Capitalization$551.5M
Shares Outstanding58.1M
Float53.4M
Dividends & Splits
Annual Dividendnone 
Last Split: 5 for 4 on 30-Nov-1983
Per-Share Data
Book Value (mrq)$2.66 
Earnings (ttm)-$0.37 
Earnings (mrq)$0.12 
Sales (ttm)$1.87 
Cash (mrq)$1.94 
Valuation Ratios
Price/Book (mrq)3.58 
Price/EarningsN/A 
Price/Sales (ttm)5.09 
Income Statements
Sales (ttm)$105.3M
EBITDA (ttm)-$9.53M
Income available to common (ttm)-$19.9M
Profitability
Profit Margin (ttm)-18.9%
Operating Margin (ttm)-11.1%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-9.40%
Return on Equity (ttm)-12.87%
Financial Strength
Current Ratio (mrq)6.57 
Debt/Equity (mrq)0.13 
Total Cash (mrq)$112.5M
Short Interest
As of 8-Aug-2001
Shares Short2.85M
Percent of Float5.3%
Shares Short
(Prior Month)
3.20M
Short Ratio9.12 
Daily Volume312.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.